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Tuberculosis is a major cause of death worldwide. Understanding of the
pathogenicity of Mycobacterium tuberculosis has been advanced by gene
analysis and has led to the identiﬁcation of genes that are important for
intracellular survival in macrophages. One of these genes encodes HsaD, a meta-
cleavage product (MCP) hydrolase that catalyzes the hydrolytic cleavage of a
carbon–carbon bond in cholesterol metabolism. This paper describes the
production of HsaD as a recombinant protein and, following crystallization, the
determination of its three-dimensional structure to 2.35 A ˚ resolution by X-ray
crystallography at the Diamond Light Source in Oxfordshire, England. To the
authors’ knowledge, this study constitutes the ﬁrst report of a structure
determined at the new synchrotron facility. The volume of the active-site cleft of
the HsaD enzyme is more than double the corresponding active-site volumes of
related MCP hydrolases involved in the catabolism of aromatic compounds,
consistent with the speciﬁcity of HsaD for steroids such as cholesterol.
Knowledge of the structure of the enzyme facilitates the design of inhibitors.
1. Introduction
HsaD is a member of the   -hydrolase superfamily, which includes
the meta-cleavage product (MCP) hydrolases (Seah et al., 2007). MCP
hydrolases occur in the microbial pathways responsible for the
aerobic catabolism of aromatic compounds, catalysing the hydrolytic
cleavage of a carbon–carbon bond in the 2-hydroxy-6-oxo-dienoates
that result from the meta cleavage of catechols by extradiol dioxy-
genases. HsaD from Mycobacterium tuberculosis H37Rv is a class I
MCP hydrolase; this class includes enzymes involved in steroid
and biphenyl catabolism (Seah et al., 2007). Recent work has
demonstrated that HsaD has high speciﬁcity for the steroid MCP 4,5-
9,10-diseco-3-hydroxy-5,9,17-trioxoandrosta-1(10),2-diene-4-oic acid
(4,9-DHSA) and is involved in cholesterol catabolism (Van der Geize
et al., 2007). The gene encoding HsaD in M.tuberculosis isfound in an
operon which was predicted (Payton et al., 2001) and subsequently
shown (Anderton et al., 2006) to consist of genes encoding HsaA,
HsaD, HsaC, HsaB(Van der Geize et al., 2007), a hypothetical protein
and an arylamine N-acetyltranferase (NAT), as shown in Fig. 1. The
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Figure 1
The hsa operon in M. tuberculosis and M. bovis BCG. The accession numbers for the genes in M. tuberculosis H37Rv,
ordered from right to left, are Rv3570c, Rv3569c, Rv3568c, Rv3567c, Rv3566A and Rv3566c. The corresponding genes
in M. bovis BCG have accession numbers Mb3601c, Mb3600c, Mb3599c, Mb3598c, Mb3597c and Mb3596c.nat gene has been shown to be required for intracellular survival of
the M. tuberculosis model organism M. bovis BCG inside macro-
phage cells (Bhakta et al., 2004). The phenotype following ablation of
the nat gene in M. bovis BCG was mimicked by growing the wild-type
organism in the presence of a putative substrate of HsaC to act as a
competitive inhibitor of this enzyme (Anderton et al., 2006). Large-
scale transposon-mutagenesis studies have suggested that the genes
encoding HsaA and HsaD are also essential for intracellular survival
of M. tuberculosis in human macrophages (Rengarajan et al., 2005).
Recent work has demonstrated that this operon is part of a larger
regulon that is involved in lipid metabolism (Kendall et al., 2007).
Therefore, the enzymes encoded by the genes in this operon are
important for understanding the biology of M. tuberculosis and also
represent potential therapeutic targets.
In this paper, we report the 2.35 A ˚ resolution structure of HsaD
from M. tuberculosis solved by X-ray crystallography at the Diamond
Light Source synchrotron.
2. Materials and methods
2.1. Production and purification of HsaD
The HsaD open reading frame was cloned from M. tuberculosis
strain H37Rv into the expression vector pVLT31 with a 20-amino-
acid N-terminal hexahistidine tag (amino-acid sequence MGSSH-
HHHHHSSGLVPR). The expression host used was Pseudomonas
putida KT4224. Heterologous expression in LB medium at 303 K
gave a typical yield of 15 mg HsaD protein per litre of bacterial
culture after puriﬁcation by immobilized nickel-ion afﬁnity chroma-
tography. The N-terminal hexahistidine tag could not be removed
from the recombinant protein by thrombin cleavage. Details of the
cloning, expression and protein puriﬁcation will be published else-
where.
2.2. Crystallization and structure solution
Puriﬁed recombinant HsaD protein (in 100 mM sodium phosphate
pH 7.4) was concentrated to 10 mg ml
 1 with an Amicon ultra-
centrifugation concentrator (Millipore, Watford, Hertfordshire). The
crystals described in this paper were grown at 292 K by the sitting-
drop vapour-diffusion method. For crystallization, 150 nl concen-
trated HsaD solution was mixed with 150 nl precipitant [30%(w/v)
PEG 3000, 0.1 M CHES pH 9.5] and the volume of precipitant in the
reservoir was 100 ml. Crystals typically grew within 3–5 d.
Crystals were brieﬂy transferred to a cryoprotectant solution [a
3:1(v:v) mixture of precipitant and glycerol] prior to ﬂash-freezing in
liquid nitrogen. Diffraction data were collected from one plate-
shaped crystal of approximate dimensions 50   50   10 mma t
beamline IO4 at the Diamond Light Source, Oxfordshire, England.
Data from 178 images (oscillation range 0.5 ) were indexed and
integrated with MOSFLM (Leslie, 1992) and scaled with SCALA
(Evans, 2006). Initial phases were determined by molecular repla-
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Figure 2
Sequence alignmentof the HsaD protein from M. tuberculosis with BphDs from B.xenovorans(PDB code 2og1) andR. jostii RHA1 (PDB code 1c4x) andMphC from E.coli
(PDB code 1u2e). The structure of HsaD from M. tuberculosis was used to generate the structural annotations. The catalytic triad residues Ser114, His269 and Asp241
(M. tuberculosis HsaD numbering) are indicated by black stars. The alignment was performed with ClustalW (Chenna et al., 2003) and the ﬁgure was prepared with ESPRIPT
(Gouet et al., 1999).cement with the program Phaser (Read, 2001) by using an ensemble
of the MCP hydrolases from Burkholderia xenovorans LB400 (PDB
code 2og1; Horsman et al., 2006) and Rhodococcus jostii RHA1
1
(PDB code 1c4x; Nandhagopal et al., 1997) as search templates, with
nonconserved residues truncated to the C
  atom with the program
CHAINSAW (Schwarzenbacher et al., 2004). Initial model building
was performed with ARP/wARP (Morris et al., 2003) and was
followed by iterative cycles of manual building with Coot (Emsley &
Cowtan, 2004), reﬁnement with REFMAC (Murshudov et al., 1997) or
phenix.reﬁne (Adams et al., 2002) and model-quality checking with
MOLPROBITY (Davis et al., 2007). The protein model was solvated
and the waters checked with phenix.reﬁne and Coot. The stereo-
chemical quality of the ﬁnal model was assessed with the programs
MOLPROBITY and PROCHECK (Laskowski et al., 1993). Data-
collection and reﬁnement statistics are shown in Table 1.
3. Results and discussion
The recombinant M. tuberculosis HsaD protein was produced, puri-
ﬁed and crystallized as described in x2. A summary of the data-
collection and reﬁnement statistics is presented in Table 1. The
asymmetric unit of the M. tuberculosis HsaD crystal structure consists
of two chains, each of 284 amino-acid residues (Leu7–Gly290). The
electron density was not sufﬁciently well resolved to model the 26
protein structure communications
4 Lack et al.   HsaD Acta Cryst. (2008). F64, 2–7
Figure 3
(a, b) Orthogonal views of the ribbon structurs of HsaD from M. tuberculosis (PDB code 2vf2, purple) aligned with those of the BphD enzymes from B. xenovorans LB400
(PDB code 2og1, green) and R. jostii RHA1 (PDB code 1c4x, cyan) and of MphC from E. coli (PDB code 1u2e, yellow). (c) A view of the overlay highlighting the region
correlating to amino acids 199–232 in M. tuberculosis HsaD. (d) A view highlighting the  -helical lid domain of M. tuberculosis HsaD. The structural alignments were
performed by secondary-structure matching (SSM)i nCCP4mg (Krissinel & Henrick, 2004; Potterton et al., 2004).
1 Formerly Rhodococcus sp. RHA1; the species was recently identiﬁed by
A. L. Jones and M. Goodfellow (personal communication).N-terminal residues, which include the 20-amino-acid hexahistidine
afﬁnity tag used for protein puriﬁcation, or the C-terminal arginine
residue.
The M. tuberculosis HsaD enzyme shares only modest amino-acid
sequence identity with other MCP hydrolases, including MhpC from
Escherichia coli (Dunn et al., 2005) and the BphD enzymes from
B. xenovorans LB400 (Horsman et al., 2006) and R. jostii RHA1
(Nandhagopal et al., 1997), as shown in Table 2. Despite these modest
sequence identities, the M. tuberculosis HsaD protein adopts a three-
dimensional fold which is highly similar to those of these known MCP
hydrolases. The root-mean-square deviations of the C
  backbone
atoms between M. tuberculosis HsaD and each of these three MCP
hydrolases are given in Table 2. Fig. 2 shows a sequence alignment of
these four proteins; an overlay of their three-dimensional structures
is shown in Fig. 3.
In all four crystal structures shown in Fig. 3 an  -helical lid domain
( 5– 5, amino acids 153–232) is encompassed by an  / -domain. The
 / -domain is made up of a central  -sheet consisting of three anti-
parallel strands followed by ﬁve parallel strands (from the
N-terminus to the C-terminus), surrounded by ﬁve  -helices. The
active sites of MCP hydrolases are composed of a polar portion (P)
and a nonpolar portion (NP) (Seah et al., 2007), with a well conserved
central catalytic triad of residues, Ser114, His269 and Asp241
(M. tuberculosis HsaD numbering). Of these three residues, only the
histidine is conserved throughout all known   -hydrolases and recent
studies have explored the mechanistic role of the active-site histidine
residue of BphD from B. xenovorans (Horsman et al., 2007). The NP
subsite of M. tuberculosis HsaD appears to be the entrance to the
active-site cleft, in contrast to the proposed active-site entrance (P
subsite) of R. jostii RHA1 BphD (Nandhagopal et al., 2001). One key
difference in the three-dimensional fold of M. tuberculosis HsaD
relative to these other three MCP hydrolases is the location of amino-
acid residues 213–224 (HsaD numbering), which stretches from the
C-terminus of  8 to the end of  4 (Fig. 3) and forms one edge of the
NP subsite. The corresponding regions in the other MCP hydrolases
are closer to the catalytic triad, resulting in a signiﬁcantly smaller NP
subsite in these proteins relative to M. tuberculosis HsaD (Fig. 4). The
calculated volume of the NP portion of the active-site cavity of
M. tuberculosis HsaD ( 2100 A ˚ 3) was approximately twofold larger
than the corresponding cavity in B. xenovorans BphD ( 1200 A ˚ 3)
and around fourfold larger than the cavities in the other two MCP
hydrolases shown in Fig. 4 ( 500 A ˚ 3), as determined from the PDB
ﬁles using the program VOIDOO (Kleywegt & Jones, 1994). This
large nonpolar portion of the active site is consistent with the role of
M. tuberculosis HsaD in hydrolysis of the cholesterol MCP
4,9-DHSA (Van der Geize et al., 2007).
The M. tuberculosis HsaD protein structure was found to adopt a
tetrameric assembly in the protein crystal, as shown in Fig. 5. This
tetrahedral structure may be described as a dimer of dimers in which
the two monomers in each dimer (green/yellow and blue/magenta in
protein structure communications
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Figure 4
Comparison of the nonpolar (NP) portion of the active-site surfaces of (a) M. tuberculosis HsaD (PDB code 2vf2), (b) BphD from R. jostii RHA1 (PDB code 1c4x), (c)
MphC from E. coli (PDB code 1u2e) and (d) BphD from B. xenovorans (PDB code 2og1). The surfaces are coloured by electrostatic potential. The surfaces were calculated
for the overlaid structures (Fig. 3) and the ﬁgure was prepared with CCP4mg.Fig. 5) are arranged such that an extended 16-strand  -sheet is
formed. This tetrahedral assembly was predicted to be stable in
solution using the PISA web service at the European Bioinformatics
Institute (Krissinel & Henrick, 2007). The active site of each
monomer appears to be distinct and the entrance to each active site
(e.g. Fig. 5a) is in close proximity to the monomer–monomer  -sheet
interface of the opposite dimer (e.g. B–B0). It may therefore be
possible for particularly large or long-chain substrates bound at the
active site to also interact with residues on the opposite dimer. The
equivalent multimeric assemblies of the MCP hydrolases from
B. xenovorans (PDB code 2og1) and E. coli (PDB code 1u2e) have
also been described (Dunn et al., 2005; Horsman et al., 2006).
In summary, the three-dimensional structure of the HsaD protein
from M. tuberculosis has been determined by X-ray crystallography
at the Diamond Light Source in Oxfordshire, England. The structure
shows very high overall similarity to those of other known MCP
hydrolases, with the notable exception of one region bounding the
active-site pocket. The result of this difference is a larger active site
relative to the previously described MCP hydrolases, which is
consistent with the substrate speciﬁcity of HsaD from M. tuberculosis.
The gene encoding HsaD has previously been shown to be essential
for the survival of M. tuberculosis inside macrophages and therefore
this structure provides a basis for rational ligand design, which will be
important both for understanding the biology of M. tuberculosis and
for the development of novel antituberculosis agents.
The authors thank the Wellcome Trust for ﬁnancial support. NL is
in receipt of a Canadian National Scholarship (Linacre College,
University of Oxford) and a Natural Sciences and Engineering
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Table 2












versus HsaD (A ˚ ) Reference
MhpC, E. coli 1u2e 36 1.51 Dunn et al. (2005)
BphD, B. xenovorans 2og1 44 1.43 Horsman et al. (2006)
BphD, R. jostii RHA1 1c4x 29 1.71 Nandhagopal et al. (1997)
Figure 5
The predicted tetrahedral tetrameric assembly of M. tuberculosis HsaD in solution. The molecular assembly was predicted using the Protein Interfaces, Surfaces and
Assemblies service (PISA) at the European Bioinformatics Institute (http://www.ebi.ac.uk/msd-srv/prot_int/pistart.html; Krissinel & Henrick, 2007). The assembly may be
described as a dimer of dimers in which the monomers coloured green and yellow form one dimer and the monomers coloured blue and magenta form the second dimer. The
view in (b) was generated by rotating view (a) by 180  around the y axis. The ﬁgure was prepared with CCP4mg.
Table 1
Summary of data-collection and reﬁnement statistics.
Values in parentheses are for the highest resolution shell.
Space group I212121
Unit-cell parameters a = 82.36, b = 82.46, c = 194.67,
  =   =   =9 0
Data-collection statistics
Wavelength (A ˚ ) 0.96800
Resolution (A ˚ ) 32.4–2.35 (2.48–2.35)
No. of unique reﬂections 24657 (3312)
Rmerge† 0.075 (0.50)
I/ (I) 7.9 (1.5)
Completeness (%) 96.7 (93.6)
Redundancy 3.4 (3.4)
Reﬁnement and model statistics
Resolution (A ˚ ) 32.4–2.35 (2.40–2.35)
No. reﬂections used (work + test) 24657
Rwork‡ 0.212 (0.305)
Rfree‡ 0.233 (0.294)
No. of residues (chain A/chain B) 284/284
No. of water molecules 208
Additional molecules 3 glycerol, 2 sulfate
Total No. of atoms 4624
R.m.s.d. bond lengths (A ˚ ) 0.015
R.m.s.d. bond angles ( ) 0.81
Mean B factor (A ˚ 2) 54.1
Ramachandran statistics (%)
Core region 88.4











i IiðhklÞ, where Ii(hkl) is the intensity of the
ith observation of unique reﬂection h.‡ Rwork and Rfree =
P
h
   jFoðhÞj  
jFcðhÞj
   =
P
h jFoðhÞj for the working set and test set (5%) of reﬂections, where Fo(h)
and Fc(h) are the observed and calculated structure-factor amplitudes for reﬂection h.Research Council of Canada (NSERC) Scholarship. LDE acknowl-
edges support from the Canadian Institutes for Health Research
(CIHR). The authors also thank Sanjib Bhakta (Birkbeck College,
London) for M. tuberculosis genomic DNA and the beamline scien-
tists at IO4 of the Diamond Light Source for technical support.
References
Adams, P. D., Grosse-Kunstleve, R. W., Hung, L.-W., Ioerger, T. R., McCoy,
A. J., Moriarty, N. W., Read, R. J., Sacchettini, J. C., Sauter, N. K. &
Terwilliger, T. C. (2002). Acta Cryst. D58, 1948–1954.
Anderton, M. C., Bhakta, S., Besra, G. S., Jeavons, P., Eltis, L. D. & Sim, E.
(2006). Mol. Microbiol. 59, 181–192.
Bhakta, S., Besra, G. S., Upton, A. M., Parish, T., Sholto-Douglas-Vernon, C.,
Gibson, K. J. C., Knutton, S., Gordon, S., daSilva, R. P., Anderton, M. C. &
Sim, E. (2004). J. Exp. Med. 199, 1191–1199.
Chenna, R., Sugawara, H., Koike, T., Lopez, R., Gibson, T. J., Higgins, D. G. &
Thompson, J. D. (2003). Nucleic Acids Res. 31, 3497–3500.
Davis, I. W., Leaver-Fay, A., Chen, V. B., Block, J. N., Kapral, G. J., Wang, X.,
Murray, L. W., Arendall, W. B. III, Snoeyink, J., Richardson, J. S. &
Richardson, D. C. (2007). Nucleic Acids Res. 35, W375–W383.
Dunn, G., Montgomery, M. G., Mohammed, F., Coker, A., Cooper, J. B.,
Robertson, T., Garcia, J. L., Bugg, T. D. & Wood, S. P. (2005). J. Mol. Biol.
346, 253–265.
Emsley, P. & Cowtan, K. (2004). Acta Cryst. D60, 2126–2132.
Evans, P. (2006). Acta Cryst. D62, 72–82.
Gouet, P., Courcelle, E., Stuart, D. I. & Metoz, F. (1999). Bioinformatics, 15,
305–308.
Horsman, G. P., Bhowmik, S., Seah, S. Y., Kumar, P., Bolin, J. T. & Eltis, L. D.
(2007). J. Biol. Chem. 282, 19894–19904.
Horsman, G. P., Ke, J., Dai, S., Seah, S. Y., Bolin, J. T. & Eltis, L. D. (2006).
Biochemistry, 45, 11071–11086.
Kendall, S. L., Withers, M., Soffair, C. N., Moreland, N. J., Gurcha, S., Sidders,
B., Frita, R., Ten Bokum, A., Besra, G. S., Lott, J. S. & Stoker, N. G. (2007).
Mol. Microbiol. 65, 684–699.
Kleywegt, G. J. & Jones, T. A. (1994). Acta Cryst. D50, 178–185.
Krissinel, E. & Henrick, K. (2004). Acta Cryst. D60, 2256–2268.
Krissinel, E. & Henrick, K. (2007). J. Mol. Biol. 372, 774–797.
Laskowski, R. A., MacArthur, M. W., Moss, D. S. & Thornton, J. M. (1993). J.
Appl. Cryst. 26, 283–291.
Leslie,A.G.W. (1992).JntCCP4/ESF–EACBMNewsl. ProteinCrystallogr.26.
Morris, R. J., Perrakis, A. & Lamzin, V. S. (2003). Methods Enzymol. 374,
229–244.
Murshudov, G. N., Vagin, A. A. & Dodson, E. J. (1997). Acta Cryst. D53,
240–255.
Nandhagopal, N., Senda, T., Hatta, T., Yamada, A., Masai, E., Fukuda, M. &
Mitsui, Y. (1997). Proc. Jpn Acad. Ser. B, 73, 154–157.
Nandhagopal, N., Yamada, A., Hatta, T., Masai, E., Fukuda, M., Mitsui, Y. &
Senda, T. (2001). J. Mol. Biol. 309, 1139–1151.
Payton, M., Mushtaq, A., Yu, T. W., Wu, L. J., Sinclair, J. & Sim, E. (2001).
Microbiology, 147, 1137–1147.
Potterton, L., McNicholas, S., Krissinel, E., Gruber, J., Cowtan, K., Emsley, P.,
Murshudov, G. N., Cohen, S., Perrakis, A. & Noble, M. (2004). Acta Cryst.
D60, 2288–2294.
Read, R. J. (2001). Acta Cryst. D57, 1373–1382.
Rengarajan, J., Bloom, B. R. & Rubin, E. J. (2005). Proc. Natl Acad. Sci. USA,
102, 8327–8332.
Schwarzenbacher, R., Godzik, A., Grzechnik, S. K. & Jaroszewski, L. (2004).
Acta Cryst. D60, 1229–1236.
Seah, S. Y., Ke, J., Denis, G., Horsman,G. P., Fortin, P. D., Whiting, C. J. & Eltis,
L. D. (2007). J. Bacteriol. 189, 4038–4045.
Van der Geize, R., Heuser, T., Yam, K., Wilbrink, M., Hara, H., Anderton,
M. C., Sim, E., Dijkhuizen, L., Davies, J., Mohn, W. & Eltis, L. D. (2007).
Proc. Natl Acad. Sci. USA, 104, 1947–1952.
protein structure communications
Acta Cryst. (2008). F64, 2–7 Lack et al.   HsaD 7